Bristol-Myers Squibb Co
NYSE:BMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bristol-Myers Squibb Co
NYSE:BMY
|
US |
|
U
|
United Overseas Insurance Ltd
SGX:U13
|
SG |
|
S
|
Sunrun Inc
LSE:0A4S
|
US |
|
K
|
Kimberly-Clark Corp
DUS:KMY
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
O
|
OneJoon Co Ltd
KOSDAQ:382840
|
KR |
|
Develop Global Ltd
F:IHB1
|
AU |
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
|
Adani Green Energy Ltd
BSE:541450
|
IN |
|
Equinix Inc
NASDAQ:EQIX
|
US |
|
J
|
Jack Chia Industries Thailand PCL
SET:JCT
|
TH |
|
F
|
Friwo AG
F:CEA
|
DE |
|
T
|
Thai Mui Corporation PCL
SET:THMUI
|
TH |
|
Steel Dynamics Inc
NASDAQ:STLD
|
US |
|
Arkema SA
PAR:AKE
|
FR |
|
I
|
Infotel SA
F:3NH
|
FR |
|
X
|
Xali Gold Corp
OTC:CGDXF
|
CA |
|
B
|
BioInvent International AB
STO:BINV
|
SE |
|
Mastercraft Boat Holdings Inc
NASDAQ:MCFT
|
US |
|
N
|
National Bank of Canada
XMUN:NBC
|
CA |
|
Z
|
Zalando SE
F:ZAL
|
DE |
|
E
|
EnBio Co Ltd
KOSDAQ:352940
|
KR |
|
Huatai Securities Co Ltd
OTC:HUATF
|
CN |
Intrinsic Value
Is BMY undervalued or overvalued?
See the intrinsic value estimate for Bristol-Myers Squibb Co and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Bristol-Myers Squibb Does
Bristol-Myers Squibb is a global drugmaker that develops, manufactures, and sells prescription medicines for serious diseases. Its products are used mainly in cancer, heart disease, immune disorders, and blood diseases. The company spends heavily on research, clinical trials, and regulatory approval because its business depends on turning scientific discoveries into approved medicines.
- Headquarters
- United States of America US
- Employees
- 32 500
- IPO date
- Mar 17, 1980
Bristol-Myers Squibb has a wide economic moat
Patents and legal protection against copies prevent rivals from freely reproducing Bristol Myers Squibb’s protected medicines and competing mainly on price. These protections cover a broad range of treatments, including cancer drugs and medicines for heart and immune conditions, rather than depending on a single discovery.
Read the full moat analysis
Revenue & Expenses Breakdown
Bristol-Myers Squibb Co
Earnings Waterfall
Bristol-Myers Squibb Co
The intrinsic value for Bristol-Myers Squibb Co (BMY) under the Base Case is hidden USD.
Compared with the current market price of 62.54 USD, the stock appears hidden.